Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Horwitz

Showing results (31-40 of 453) with videos related to

Pageof 46
Sort By:
The Lancet. Neurology|July 24, 2010
Emerging effects of comorbidities on multiple sclerosisRuth Ann Marrie, Ralph I Horwitz
The Journal of Rheumatology. Supplement|October 1, 1996
Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndromeR I Horwitz, S R Daniels
The American Journal of Medicine|September 1, 1983
Conflicting clinical trials and the uncertainty of treating mild hypertensionP J Toth, R I Horwitz
CA: a Cancer Journal for Clinicians|July 1, 1979
Community surveillance bias and the estrogen-endometrial cancer disputeR I Horwitz, A R Feinstein
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 1, 1995
Oral cancer and mouthwash use: evaluation of the epidemiologic evidenceJ G Elmore, R I Horwitz
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Scientific standards and the design of case-control researchT F Imperiale, R I Horwitz
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Longitudinal methods for evaluating therapyJ D Clemens, R I Horwitz
The American Journal of Medicine|February 1, 1980
The problem of "protopathic bias" in case-control studiesR I Horwitz, A R Feinstein
The Journal of Clinical Pharmacology and New Drugs|July 1, 1980
Advantages and drawbacks of the Zelen design for randomized clinical trialsRalph I Horwitz, Alvan R Feinstein
The New England Journal of Medicine|April 19, 1979
Estrogen use and endometrial cancerR I Horwitz, A R Feinstein
Pageof 46

Showing results (31-40 of 453) with videos related to

Sort By:
Pageof 46
The Lancet. Neurology|July 24, 2010
Emerging effects of comorbidities on multiple sclerosisRuth Ann Marrie, Ralph I Horwitz
The Journal of Rheumatology. Supplement|October 1, 1996
Bias or biology: evaluating the epidemiologic studies of L-tryptophan and the eosinophilia-myalgia syndromeR I Horwitz, S R Daniels
The American Journal of Medicine|September 1, 1983
Conflicting clinical trials and the uncertainty of treating mild hypertensionP J Toth, R I Horwitz
CA: a Cancer Journal for Clinicians|July 1, 1979
Community surveillance bias and the estrogen-endometrial cancer disputeR I Horwitz, A R Feinstein
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 1, 1995
Oral cancer and mouthwash use: evaluation of the epidemiologic evidenceJ G Elmore, R I Horwitz
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1989
Scientific standards and the design of case-control researchT F Imperiale, R I Horwitz
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 1, 1984
Longitudinal methods for evaluating therapyJ D Clemens, R I Horwitz
The American Journal of Medicine|February 1, 1980
The problem of "protopathic bias" in case-control studiesR I Horwitz, A R Feinstein
The Journal of Clinical Pharmacology and New Drugs|July 1, 1980
Advantages and drawbacks of the Zelen design for randomized clinical trialsRalph I Horwitz, Alvan R Feinstein
The New England Journal of Medicine|April 19, 1979
Estrogen use and endometrial cancerR I Horwitz, A R Feinstein
Pageof 46